If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
492.00    2.00 (0.41%)
Bid:
490.00
Ask:
495.00
Spread: 5.00 (1.02%)
Market Cap: £810.64m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Update from QuotedData

2 Apr 2024 16:17

RNS Number : 0296J
Oakley Capital Investments Limited
02 April 2024
 

 

Oakley Capital Investments - Update from QuotedData

2nd April 2024

Getting down to business

In spite of an uncertain macroeconomic environment, Oakley Capital Investments' (OCI) underlying portfolio continued to generate robust earnings growth in 2023 (average 14% EBITDA growth), which in turn drove 4% net asset value (NAV) growth. More importantly, OCI achieved an 18% total shareholder return during the period, extending the long run of strong share price performance delivered by the company (an average compound annual growth rate of 24% per year).

The same macroeconomic uncertainty is also creating opportunity as OCI's investment manager Oakley has been busy deploying cash into new investments at what it feels are attractive valuations.

There appears to have been a particular focus on building the portfolio's exposure to the business services sector. This note provides a deeper dive into OCI's investments in this area.

Full Research:

https://quoteddata.com/research/oakley-capital-investments-business-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Oakley Capital Investments Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUUAVRSVUSRAR
Date   Source Headline
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment
14th Nov 20183:58 pmRNSDirector Dealing
8th Nov 20187:00 amRNSInvestment Activity Update
24th Oct 20181:30 pmRNSDirector Dealing
12th Oct 20183:07 pmRNSDirector Dealing
25th Sep 20187:00 amRNSAppointment of Non-Executive Director
11th Sep 20187:00 amRNSBoard Changes
6th Sep 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSOakley Capital to invest in cPanel
27th Jul 20184:40 pmRNSHolding(s) in Company
26th Jul 20187:00 amRNSTrading Update
6th Jul 20187:00 amRNSOakley agrees sale of Damovo to Eli Global
4th Jul 20183:49 pmRNSResult of AGM
28th Jun 20186:21 pmRNSDirector Dealing
28th Jun 20186:20 pmRNSDirector Dealing
26th Jun 201811:29 amRNSDirector Dealing
21st Jun 20187:00 amRNSNotice of Annual General Meeting
11th Jun 20187:00 amRNSPlesk acquisition of SolusVM
24th May 20187:00 amRNSOakley agrees sale of Facile to EQT
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20183:35 pmRNSDirector/PDMR Shareholding
26th Apr 20183:34 pmRNSDirector/PDMR Shareholding
13th Apr 20182:00 pmRNSDirector/PDMR Shareholding
20th Mar 201812:54 pmRNSDividend Announcement
15th Mar 20187:00 amRNSFinal Results
6th Mar 201811:57 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSSale of PARSHIP ELITE Group and Verivox
31st Jan 20187:00 amRNSTrading Update
18th Jan 20185:26 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSAcquisition of Career Partner Group
19th Sep 20177:00 amRNSDirector/PDMR Shareholding
15th Sep 20178:57 amRNSDirector/PDMR Shareholding
12th Sep 20177:00 amRNSHalf-year Report
3rd Aug 20177:00 amRNSTrading Update
31st Jul 20177:00 amRNSChange of Stock Ticker
28th Jul 20177:00 amRNSInspired welcomes TA Associates as an investor
10th Jul 20173:10 pmRNSCompletion of Schülerhilfe Acquisition
20th Jun 201712:42 pmRNSHolding(s) in Company
16th Jun 201711:03 amRNSResult of AGM
26th May 20177:00 amRNSCompletion of TechInsights Acquisition
16th May 20175:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.